1026 related articles for article (PubMed ID: 16950988)
1. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
3. [Time for booster doses against whooping cough for 10-year-old children].
Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
[TBL] [Abstract][Full Text] [Related]
4. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
[TBL] [Abstract][Full Text] [Related]
5. Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden.
Carlsson RM; Trollfors B
Vaccine; 2009 Sep; 27(42):5709-18. PubMed ID: 19679218
[TBL] [Abstract][Full Text] [Related]
6. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
7. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
[TBL] [Abstract][Full Text] [Related]
8. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
[TBL] [Abstract][Full Text] [Related]
9. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
Matter HC; Schmidt-Schläpfer G; Zimmermann H
Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
[TBL] [Abstract][Full Text] [Related]
11. Control of pertussis in the world.
Galazka A
World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
[TBL] [Abstract][Full Text] [Related]
12. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
[TBL] [Abstract][Full Text] [Related]
13. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
Rendi-Wagner P; Kundi M; Mikolasek A; Vécsei A; Frühwirth M; Kollaritsch H
Vaccine; 2006 Aug; 24(33-34):5960-5. PubMed ID: 16757063
[TBL] [Abstract][Full Text] [Related]
14. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
Olin P
Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
[TBL] [Abstract][Full Text] [Related]
15. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
Elomaa A; He Q; Minh NN; Mertsola J
Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
[TBL] [Abstract][Full Text] [Related]
16. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
17. [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].
de Greeff SC; Schellekens JF; Mooi FR; de Melker HE
Ned Tijdschr Geneeskd; 2005 Apr; 149(17):937-43. PubMed ID: 15884408
[TBL] [Abstract][Full Text] [Related]
18. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose.
Hallander HO; Gustafsson L; Ljungman M; Storsaeter J
Vaccine; 2005 Nov; 23(46-47):5359-64. PubMed ID: 16051400
[TBL] [Abstract][Full Text] [Related]
19. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
20. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
